70 related articles for article (PubMed ID: 3400350)
1. [Reactions of tumorous urinary bladders following local and systemic therapy with cytostatic drugs].
Theuring F; Ecke M; Lenz E; Langen L
Z Urol Nephrol; 1988 Apr; 81(4):219-25. PubMed ID: 3400350
[TBL] [Abstract][Full Text] [Related]
2. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
Fujimoto K; Chihara Y; Kondo H; Hirao Y
Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
4. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
Trifard F; Chrétien Y; Vallantin X; Collet C; Lachand AT; Dufour B
Ann Urol (Paris); 1988; 22(3):216-9. PubMed ID: 3401004
[TBL] [Abstract][Full Text] [Related]
5. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
Guazzieri S; Sperandio P; Fandella A; Garbeglio A; Pegoraro V; Chiarion V; Fiorentino M; Pagano F
Prog Clin Biol Res; 1988; 260():599-602. PubMed ID: 3362909
[No Abstract] [Full Text] [Related]
6. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
7. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary results of prophylactic adjuvant chemotherapy with CISCA in bladder tumors].
Bittard H
J Urol (Paris); 1988; 94(7):345-7. PubMed ID: 2464650
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
10. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
[No Abstract] [Full Text] [Related]
11. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
12. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
13. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer].
Dunchik VN; Drozdovskiĭ BIa; Kariakin OB; Grishin GN
Urol Nefrol (Mosk); 1985; (2):19-23. PubMed ID: 3992752
[No Abstract] [Full Text] [Related]
14. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
[TBL] [Abstract][Full Text] [Related]
16. [Pathological changes associated with topical chemotherapy of adriamycin for bladder cancer].
Fujioka T; Ishii N; Chiba R
Hinyokika Kiyo; 1983 Aug; 29(8):869-73. PubMed ID: 6675437
[TBL] [Abstract][Full Text] [Related]
17. [Intraarterial chemotherapy with bladder preservation in patients with invasive bladder carcinoma].
Shiba M; Takatera H; Fujii T; Tokizane T; Shimizu K; Tushima J
Hinyokika Kiyo; 2004 Jan; 50(1):15-9. PubMed ID: 15032009
[TBL] [Abstract][Full Text] [Related]
18. [Intra-arterial chemotherapy for invasive bladder cancer].
Naito H; Masui M; Imamoto T; Ishiki S; Komiya A; Ito H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1948-50. PubMed ID: 10560433
[TBL] [Abstract][Full Text] [Related]
19. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
[TBL] [Abstract][Full Text] [Related]
20. [A case of anaphylactic shock induced by pirarubicin hydrochloride].
Mitsuhashi M; Iwata H; Kiyota A; Kamizuru M; Nakatani T
Hinyokika Kiyo; 2004 Apr; 50(4):257-9. PubMed ID: 15188619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
